Source: Eur Respir J 2006; 28: 1076-1078



Rating:

Share or cite this content

Citations should be made in the following way:
Schonfeld N.. The mycobacterial mystery. Eur Respir J 2006; 28: 1076-1078

Member's Comments

No comment yet.

Related content which might interest you: Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Nontuberculous mycobacterial infections Source: Eur Respir Mon 2011; 52: 115-129 Year: 2011 The role of genexpert in the diagnosis of mycobacterium tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020 Year: 2021 Pathogenicity of NTM: new developments Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007 Looking into real world practice of elder pulmonary non-tuberculous mycobacterial infection. Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Managing FDG PET-positive sarcoidosis: “a riddle wrapped in a mystery inside an enigma” Source: Eur Respir J 2016; 47: 347-348 Year: 2016 Managing FDG PET-positive sarcoidosis: “a riddle wrapped in a mystery inside an enigma” Source: Eur Respir J 2016; 47: 346-347 Year: 2016 Cell-wall deficient mycobacteria in the pathogenesis of sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 309s Year: 2001 Nontuberculous mycobacterial infections in NCFBE Source: School Course 2013 - Hot topics in the management of non-CF bronchiectasis Year: 2013 Multidrug-resistant tuberculosis around the world: what progress has been made? Source: Eur Respir J 2015; 45: 150-160 Year: 2015 A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Pre-immigration screening for pulmonary tuberculosis: the unanswered questions Source: Eur Respir J 2009; 33: 221-222 Year: 2009 Aetiopathogenesis, immunology and microbiology of tuberculosis Source: Eur Respir Monogr 2018; 82: 62-82 Year: 2018 Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT) Source: Eur Respir J 2001; 18: Suppl. 33, 307s Year: 2001 Susceptibility to nontuberculous mycobacterial lung disease Source: Eur Respir J 2008; 31: 1322-1333 Year: 2008 Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008